Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-9805 in early Parkinson's disease
NCT03189563Phase 2Completed
- Sponsor
- Dong-A ST
- Start
- Feb 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DA-9805 in Parkinson's disease (PD), sponsored by Dong-A ST. Started Feb 2018; status: completed.
02
Drugs
DA-9805
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03189563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03189563.